BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development

Development (Cambridge)

Volumn 140, Issue 6, 2013, Pages 1272-1281

  Davis, Reema B ^a,b   Curtis, Carol D ^a   Griffin, Courtney T ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Chromatin remodeling; Mouse; NR2F2; SWI SNF; Veins

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BRG1 PROTEIN; HISTONE H3; NEUROPILIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR COUP TFII; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENOTYPE; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; WILD TYPE; YOLK SAC;

ANIMALS; BLOOD VESSELS; BODY PATTERNING; CELLS, CULTURED; COUP TRANSCRIPTION FACTOR II; DNA HELICASES; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEAR PROTEINS; PREGNANCY; TRANSCRIPTION FACTORS; UP-REGULATION; VEINS;

EID: 84874550817     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.087379     Document Type: Article

References (47)

1. Adams, R. H., Wilkinson, G. A., Weiss, C., Diella, F., Gale, N. W., Deutsch, U., Risau, W. and Klein, R. (1999). Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13, 295-306.
2. Brault, V., Moore, R., Kutsch, S., Ishibashi, M., Rowitch, D. H., McMahon, A. P., Sommer, L., Boussadia, O. and Kemler, R. (2001). Inactivation of the beta- catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128, 1253-1264.
3. Carlson, T. R., Yan, Y., Wu, X., Lam, M. T., Tang, G. L., Beverly, L. J., Messina, L. M., Capobianco, A. J., Werb, Z. and Wang, R. (2005). Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc. Natl. Acad. Sci. USA 102, 9884-9889.
4. Chen, X., Qin, J., Cheng, C. M., Tsai, M. J. and Tsai, S. Y. (2012). COUP-TFII is a major regulator of cell cycle and Notch signaling pathways. Mol. Endocrinol. 26, 1268-1277.
5. Chi, J. T., Chang, H. Y., Haraldsen, G., Jahnsen, F. L., Troyanskaya, O. G., Chang, D. S., Wang, Z., Rockson, S. G., van de Rijn, M., Botstein, D. et al. (2003). Endothelial cell diversity revealed by global expression profiling. Proc. Natl. Acad. Sci. USA 100, 10623-10628.
6. Corada, M., Nyqvist, D., Orsenigo, F., Caprini, A., Giampietro, C., Taketo, M. M., Iruela-Arispe, M. L., Adams, R. H. and Dejana, E. (2010). The Wnt/beta- catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev. Cell 18, 938-949.
7. Curtis, C. D. and Griffin, C. T. (2012). The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling. Mol. Cell. Biol. 32, 1312-1320.
8. Curtis, C. D., Davis, R. B., Ingram, K. G. and Griffin, C. T. (2012). Chromatin- remodeling complex specificity and embryonic vascular development. Cell. Mol. Life Sci. 69, 3921-3931.
9. Duarte, A., Hirashima, M., Benedito, R., Trindade, A., Diniz, P., Bekman, E., Costa, L., Henrique, D. and Rossant, J. (2004). Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 18, 2474-2478.
10. Fischer, A., Schumacher, N., Maier, M., Sendtner, M. and Gessler, M. (2004). The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18, 901-911.
11. Fry, C. J. and Peterson, C. L. (2001). Chromatin remodeling enzymes: who's on first? Curr. Biol. 11, R185-R197.
12. Garcia-Cardeña, G., Comander, J., Anderson, K. R., Blackman, B. R. and Gimbrone, M. A., Jr (2001). Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc. Natl. Acad. Sci. USA 98, 4478-4485.
13. Gebuhr, T. C., Kovalev, G. I., Bultman, S., Godfrey, V., Su, L. and Magnuson, T. (2003). The role of Brg1, a catalytic subunit of mammalian chromatin- remodeling complexes, in T cell development. J. Exp. Med. 198, 1937-1949.
14. Gerety, S. S., Wang, H. U., Chen, Z. F. and Anderson, D. J. (1999). Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell 4, 403-414.
15. Griffin, C. T., Brennan, J. and Magnuson, T. (2008). The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development. Development 135, 493-500.
16. Griffin, C. T., Curtis, C. D., Davis, R. B., Muthukumar, V. and Magnuson, T. (2011). The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels. Proc. Natl. Acad. Sci. USA 108, 2282-2287.
17. Hargreaves, D. C. and Crabtree, G. R. (2011). ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res. 21, 396-420.
18. Hayashi, H. and Kume, T. (2008). Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS ONE 3, e2401.
19. Herzog, Y., Kalcheim, C., Kahane, N., Reshef, R. and Neufeld, G. (2001). Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech. Dev. 109, 115-119.
20. Ho, L. and Crabtree, G. R. (2010). Chromatin remodelling during development. Nature 463, 474-484.
21. Jones, E. A., Yuan, L., Breant, C., Watts, R. J. and Eichmann, A. (2008). Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos. Development 135, 2479-2488.
22. Kim, Y. H., Hu, H., Guevara-Gallardo, S., Lam, M. T., Fong, S. Y. and Wang, R. A. (2008). Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis. Development 135, 3755-3764.
23. Kisanuki, Y. Y., Hammer, R. E., Miyazaki, J., Williams, S. C., Richardson, J. A. and Yanagisawa, M. (2001). Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230-242.
24. Kokubo, H., Miyagawa-Tomita, S., Nakazawa, M., Saga, Y. and Johnson, R. L. (2005). Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev. Biol. 278, 301-309.
25. Koo, B. K., Lim, H. S., Song, R., Yoon, M. J., Yoon, K. J., Moon, J. S., Kim, Y. W., Kwon, M. C., Yoo, K. W., Kong, M. P. et al. (2005). Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. Development 132, 3459-3470.
26. Krebs, L. T., Shutter, J. R., Tanigaki, K., Honjo, T., Stark, K. L. and Gridley, T. (2004). Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 18, 2469-2473.
27. Krebs, L. T., Starling, C., Chervonsky, A. V. and Gridley, T. (2010). Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants. Genesis 48, 146-150.
28. Lawson, N. D., Scheer, N., Pham, V. N., Kim, C. H., Chitnis, A. B., Campos- Ortega, J. A. and Weinstein, B. M. (2001). Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128, 3675-3683.
29. Lawson, N. D., Vogel, A. M. and Weinstein, B. M. (2002). sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell 3, 127-136.
30. le Noble, F., Moyon, D., Pardanaud, L., Yuan, L., Djonov, V., Matthijsen, R., Bréant, C., Fleury, V. and Eichmann, A. (2004). Flow regulates arterial- venous differentiation in the chick embryo yolk sac. Development 131, 361-375.
31. Lin, F. J., Chen, X., Qin, J., Hong, Y. K., Tsai, M. J. and Tsai, S. Y. (2010). Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J. Clin. Invest. 120, 1694-1707.
32. Lin, F. J., Qin, J., Tang, K., Tsai, S. Y. and Tsai, M. J. (2011). Coup d'Etat: an orphan takes control. Endocr. Rev. 32, 404-421.
33. Maretto, S., Cordenonsi, M., Dupont, S., Braghetta, P., Broccoli, V., Hassan, A. B., Volpin, D., Bressan, G. M. and Piccolo, S. (2003). Mapping Wnt/beta- catenin signaling during mouse development and in colorectal tumors. Proc. Natl. Acad. Sci. USA 100, 3299-3304.
34. Nishida, H., Suzuki, T., Kondo, S., Miura, H., Fujimura, Y. and Hayashizaki, Y. (2006). Histone H3 acetylated at lysine 9 in promoter is associated with low nucleosome density in the vicinity of transcription start site in human cell. Chromosome Res. 14, 203-211.
35. Okamura, M., Kudo, H., Wakabayashi, K., Tanaka, T., Nonaka, A., Uchida, A., Tsutsumi, S., Sakakibara, I., Naito, M., Osborne, T. F. et al. (2009). COUP-TFII acts downstream of Wnt/beta-catenin signal to silence PPARgamma gene expression and repress adipogenesis. Proc. Natl. Acad. Sci. USA 106, 5819-5824.
36. Qin, J., Chen, X., Xie, X., Tsai, M. J. and Tsai, S. Y. (2010). COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis. Proc. Natl. Acad. Sci. USA 107, 3687-3692.
37. Srinivasan, R. S., Geng, X., Yang, Y., Wang, Y., Mukatira, S., Studer, M., Porto, M. P., Lagutin, O. and Oliver, G. (2010). The nuclear hormone receptor Coup- TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev. 24, 696-707.
38. Swift, M. R. and Weinstein, B. M. (2009). Arterial-venous specification during development. Circ. Res. 104, 576-588.
39. Thurston, G. and Yancopoulos, G. D. (2001). Gridlock in the blood. Nature 414, 163-164.
40. Trindade, A., Kumar, S. R., Scehnet, J. S., Lopes-da-Costa, L., Becker, J., Jiang, W., Liu, R., Gill, P. S. and Duarte, A. (2008). Overexpression of delta- like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood 112, 1720-1729.
41. Trotter, K. W. and Archer, T. K. (2008). The BRG1 transcriptional coregulator. Nucl. Recept. Signal. 6, e004.
42. Wang, S. J., Greer, P. and Auerbach, R. (1996). Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene. In Vitro Cell. Dev. Biol. Anim. 32, 292-299.
43. Wang, H. U., Chen, Z. F. and Anderson, D. J. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753.
44. Yao, L., Pan, J., Setiadi, H., Patel, K. D. and McEver, R. P. (1996). Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J. Exp. Med. 184, 81-92.
45. You, L. R., Lin, F. J., Lee, C. T., DeMayo, F. J., Tsai, M. J. and Tsai, S. Y. (2005). Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435, 98-104.
46. Zhong, T. P., Rosenberg, M., Mohideen, M. A., Weinstein, B. and Fishman, M. C. (2000). gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287, 1820-1824.
47. Zhong, T. P., Childs, S., Leu, J. P. and Fishman, M. C. (2001). Gridlock signaling pathway fashions the first embryonic artery. Nature 414, 216-220.